PCA3 PREDICTS PROSTATE BIOPSY OUTCOME IN MEN RECEIVING DUTASTERIDE: RESULTS FROM THE DUTASTERIDE REDUCE TRIAL

被引：0
|
作者：
Andriole, G. [1 ]
Aubin, S. M. J. [2 ]
Reid, J. [2 ]
Samo, M. J. [2 ]
Blase, A. [2 ]
Aussie, J. [2 ]
Rittenhouse, H. [2 ]
Roger, R. [3 ]
Groskopf, J. [2 ,3 ]
机构：
[1] Washington Univ, Sch Med, Barnes Jewish Hosp, St Louis, MO USA
[2] Gen Probe Inc, Dept Oncol, San Diego, CA USA
[3] GlaxoSmithKline Inc, Oncol Clin Dev & Med Affairs, Res Triangle Pk, NC USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60955-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [1] PCA3 PREDICTS PROSTATE BIOPSY OUTCOME IN MEN RECEIVING DUTASTERIDE: RESULTS FROM THE DUTASTERIDE REDUCE TRIAL
    Andriole, Gerald
    Aubin, Sheila
    Reid, Jennifer
    Sarno, Mark
    Blase, Amy
    Aussie, Jacqueline
    Rittenhouse, Harry
    Rittmaster, Roger
    Groskopf, Jack
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E801 - E801
  • [2] Prostate Cancer Gene 3 Score Predicts Prostate Biopsy Outcome in Men Receiving Dutasteride for Prevention of Prostate Cancer: Results From the REDUCE Trial
    Aubin, Sheila M. J.
    Reid, Jennifer
    Sarno, Mark J.
    Blase, Amy
    Aussie, Jacqueline
    Rittenhouse, Harry
    Rittmaster, Roger S.
    Andriole, Gerald L.
    Groskopf, Jack
    [J]. UROLOGY, 2011, 78 (02) : 380 - 385
  • [3] VALIDATION OF THE PCA3 MOLECULAR URINE TEST FOR PREDICTING REPEAT PROSTATE BIOPSY OUTCOME IN THE PLACEBO ARM OF THE DUTASTERIDE REDUCE TRIAL
    Marks, Leonard
    Aubin, Sheila
    Reid, Jennifer
    Sarno, Mark
    Blase, Amy
    Aussie, Jacqueline
    Rittenhouse, Harry
    Andriole, Gerald
    Rittmaster, Roger
    Groskopf, Jack
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E823 - E823
  • [4] VALIDATION OF THE PCA3 MOLECULAR URINE TEST FOR PREDICTING REPEAT PROSTATE BIOPSY OUTCOME IN THE PLACEBO ARM OF THE DUTASTERIDE REDUCE TRIAL
    Rittmaster, R.
    Aubin, S. M. J.
    Reid, J.
    Sarno, M. J.
    Blase, A.
    Aussie, J.
    Rittenhouse, H.
    Andriole, G. L.
    Groskopf, J.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 306 - 306
  • [5] PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial
    Aubin, Sheila M. J.
    Reid, Jennifer
    Sarno, Mark J.
    Blase, Amy
    Aussie, Jacqueline
    Rittenhouse, Harry
    Rittmaster, Roger
    Andriole, Gerald L.
    Groskopf, Jack
    [J]. JOURNAL OF UROLOGY, 2010, 184 (05): : 1947 - 1952
  • [6] PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial EDITORIAL COMMENT
    Ellis, William J.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (05): : 1952 - 1952
  • [7] THE UTILITY OF PSA FOR DETECTION OF PROSTATE CANCER IN MEN TRLATED WITH DUTASTERIDE RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDY
    Andriole, G. L.
    Bostwick, D.
    Brawley, O.
    Gomella, L.
    Marberger, M.
    Montorsi, F.
    Pettaway, C.
    Tammela, T.
    Teloken, C.
    Tindall, D.
    Wilson, T. H.
    Somerville, M.
    Fowler, I.
    Rittmaster, R. S.
    [J]. JOURNAL OF MENS HEALTH, 2009, 6 (03) : 269 - 269
  • [8] STATINS SLOW PROSTATE GROWTH: RESULTS FROM THE REDUCTION BY DUTASTERIDE OF CANCER EVENTS (REDUCE) TRIAL
    Muller, Roberto
    Gerber, Leah
    Moreira, Daniel
    Andriole, Gerald
    Parsons, J. Kellogg
    Fleshner, Neil
    Freedland, Stephen
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E505 - E505
  • [9] Efficacy and Safety of Dutasteride on Prostate Cancer Risk Reduction in Asian Men: The Results from the REDUCE Study
    Akaza, Hideyuki
    Kanetake, Hiroshi
    Tsukamoto, Taiji
    Miyanaga, Naoto
    Sakai, Hideki
    Masumori, Naoya
    Nakatsu, Hiroomi
    Sagiyama, Kazuyuki
    Sakamoto, Sadaaki
    Endo, Yukihiro
    Yamanouchi, Takayoshi
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : 417 - 423
  • [10] Does insulin resistance predict prostate cancer? Results from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial
    Zheng, Renning
    Daniels, James P.
    Moreira, Daniel M.
    Eslamimehr, Shakiba
    Freedland, Alexis R.
    Guerrios-Rivera, Lourdes
    Fowke, Jay H.
    Freedland, Stephen J.
    [J]. CANCER, 2024,
12345